- India's Piramal at centre of buy-out speculation - Pharmafocus
- Lilly in CV pact with India's Zydus, antipsychotic fails in Phase II - Pharma Times
- NPIL and Lilly form 'risk and reward' sharing alliance - OutSourcing-Pharma.com
- Eli Lilly, Zydus Cadila enter drug development deal - Business Standard
- Zydus Cadila and Eli Lilly announce research collaboration - Pharmaceutical Business Review
Lilly forges risk-sharing R&D alliance with India's Zydus - Pharmafocus
Lilly forges risk-sharing R&D alliance with India's ZydusPharmafocus, UKEli Lilly has forged a research collaboration with India's Zydus Cadila that sees the two companies combine their efforts in the area of cardiovascular research and development. The venture is one of a growing number of cases in which Asian companies ...

